Agilent Says $2.2B Dako Buy Will Boost Life Sciences Biz
Agilent Technologies Inc. will pick up Danish cancer diagnostics company Dako in a $2.2 billion debt-free deal with its current owner, Swedish private equity firm EQT, in a plan to augment...To view the full article, register now.
Already a subscriber? Click here to view full article